The DOI matches its Crossref record; 168 of the 168 references it cites were found in a registry or an index.
Use of bone turnover markers in postmenopausal osteoporosis
Abstract
Bone turnover comprises two processes: the removal of old bone (resorption) and the laying down of new bone (formation). N-terminal propeptide of type I procollagen (PINP) and C-telopeptide of type I collagen (CTX-I) are markers of bone formation and resorption, respectively, that are recommended for clinical use. Bone turnover markers can be measured on several occasions in one individual with good precision. However, these markers are subject to several sources of variability, including feeding (resorption decreases) and recent fracture (all markers increase for several months). Bone turnover markers are not used for diagnosis of osteoporosis and do not improve prediction of bone loss or fracture within an individual. In untreated women, very high bone turnover marker concentrations suggest secondary causes of high bone turnover (eg, bone metastases or multiple myeloma). In people with osteoporosis, bone turnover markers might be useful to assess the response to anabolic and antiresorptive therapies, to assess compliance to therapy, or to indicate possible secondary osteoporosis. Much remains to be learnt about how bone turnover markers can be used to monitor the effect of stopping bisphosphonate therapy (eg, to identify a threshold above which restarting therapy should be considered). More studies are needed to investigate the use of bone turnover markers for assessment of the bone safety of new medications.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“International consensus guidelines recommend assessment of two BTMs: procollagen type I N-terminal propeptide (PINP) (produced by osteoblasts during bone formation), and C-terminal cross-linking telopeptide of type I collagen (CTX) (released by osteoclasts during bone resorption) (8, 9).”
Citations
Cites
Neer, R. M., Arnaud, C. D., Zanchetta, J. R., Prince, R., Gaich, G. A., Reginster, J.-Y., Hodsman, A. B., Eriksen, E. F., Ish-Shalom, S., Genant, H. K., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105103441904 · Cited by 4,602
Shane, E., Burr, D., Abrahamsen, B., Adler, R. A., Brown, T. D., Cheung, A. M., Cosman, F., Curtis, J. R., Dell, R., Dempster, D. W., et al. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1998 · Cited by 2,147
Khan, A. A., Morrison, A. D., Hanley, D. A., Felsenberg, D., McCauley, L. K., O’Ryan, F., Reid, I. R., Ruggiero, S. L., Taguchi, A., Tetradis, S., et al. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2405 · Cited by 1,360
Self-citationRomosozumab in Postmenopausal Women with Low Bone Mineral Density
McClung, M. R., Grauer, A., Boonen, S., Bolognese, M. A., Brown, J. P., Diez-Perez, A., Langdahl, B. L., Reginster, J.-Y., Zanchetta, J. R., Wasserman, S. M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1305224 · Cited by 1,258
Denosumab in postmenopausal women with low bone mineral density.
McClung, M. R., Lewiecki, E. M., Cohen, S. B., Bolognese, M. A., Woodson, G. C., Moffett, A. H., Peacock, M., Miller, P. D., Lederman, S. N., Chesnut, C. H., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa044459 · Cited by 1,228
for the IOF-IFCC Bone Marker Standards Working Group, Vasikaran, S., Eastell, R., Bruyère, O., Foldes, A. J., Garnero, P., Griesmacher, A., McClung, M., Morris, H. A., Silverman, S., et al. (2011) · Osteoporosis International · doi:10.1007/s00198-010-1501-1 · Cited by 1,212
Self-citationDenosumab in men receiving androgen-deprivation therapy for prostate cancer
Smith, M. R., Egerdie, B., Toriz, N. H., Feldman, R., Tammela, T. L. J., Saad, F., Heracek, J., Szwedowski, M., Ke, C., Kupic, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0809003 · Cited by 1,140
Shane, E., Burr, D., Ebeling, P. R., Abrahamsen, B., Adler, R. A., Brown, T. D., Cheung, A. M., Cosman, F., Curtis, J. R., Dell, R., et al. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.253 · Cited by 1,116
Gharib, H., Papini, E., Paschke, R., Duick, D. S., Valcavi, R., Hegedűs, L. D., Vitti, P., Gharib, H., Papini, E., Paschke, R., et al. (2010) · Endocrine Practice · doi:10.4158/10024.gl · Cited by 1,087
Stein, G. S., & Lian, J. B. (1993) · Endocrine Reviews · doi:10.1210/edrv-14-4-424 · Cited by 1,058
Cited by
Sorted by citations
Items 301–400 of 596
Disorders of calcium metabolism
Winter, W. E., & Harris, N. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818277-2.00010-8 · Cited by 7
A History of Pivotal Advances in Clinical Research into Bone and Mineral Diseases
Cummings, S. R., & Eastell, R. (2017) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3353 · Cited by 6
Self-citationAdesina, O., Jenkins, I., Wu, Q. V., Fung, E. B., Narla, R. R., Lipkin, E. W., Mahajan, K., Konkle, B. A., & Kruse‐Jarres, R. (2019) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2019.102369 · Cited by 6
Cassidy, F. C., Lafferty, S., & Coleman, C. M. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.94271 · Cited by 5
Vatrasresth, J., Suwan, A., & Panyakhamlerd, K. (2021) · BMC Women s Health · doi:10.1186/s12905-021-01508-w · Cited by 8
Qiu, M., Tu, L., Zhao, M., Yang, M., Qi, J., Xie, Y., & Gu, J. (2022) · Bioengineered · doi:10.1080/21655979.2022.2026729 · Cited by 6
Reckelkamm, S. L., Hannemann, A., Kocher, T., Nauck, M. A., Völzke, H., Ehmke, B., Rauner, M., Alayash, Z., Baumeister, S., Nolde, M., et al. (2022) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.13649 · Cited by 6
Wiromrat, P., Namphaisan, P., Wongsurawat, N., Panamonta, O., & Nasomyont, N. (2022) · Clinical Endocrinology · doi:10.1111/cen.14809 · Cited by 6
Identifying therapeutic biomarkers of zoledronic acid by metabolomics
Li, X., Wang, Z., Ren, N., Wei, Z., Hu, W., Gu, J., Zhang, Z., Yu, X., & Wang, C. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1084453 · Cited by 6
Tsourdi, E. A., Gängler, S., Kistler-Fischbacher, M., Rauner, M., Dawson-Hughes, B. F., Orav, E. J., Tsai, L.-T., Lang, W., Kanis, J. А., Theiler, R., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae859 · Cited by 8
Effects of Gushukang for postmenopausal osteoporosis
Wang, G., Huo, L., Chen, G., & He, H. (2020) · Medicine · doi:10.1097/md.0000000000020908 · Cited by 6
Disorders of calcium and phosphate metabolism in infants and children
Salehi, M., & Leung‐Pineda, V. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-817962-8.00015-9 · Cited by 6
Niu, S., Chen, M., Yan, D., Liu, X., Guo, S., Ou, L., Fan, H., Lv, J., Wang, Q., Dong, W., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.893166 · Cited by 6
Long, Z., Wu, J., Xiang, W., Yuan, M.-X., Wu, Y., Li, J., Yu, G., & Yang, T. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/7017610 · Cited by 6
Jin, H., Huang, C., Zhang, Y., Dong, Y., Xiong, Q., Wang, D., He, Z., Shen, L., Ma, C., Wang, Z., et al. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1605279 · Cited by 6
Man, Y., Na, J., Wang, H., Lan, F., & Yu, L. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1592184 · Cited by 5
Neutrophil-to-albumin ratio: a novel predictor of osteoporosis in rheumatoid arthritis
Zhang, Y., He, Z., Li, K., Wu, Q., Wang, S., Liu, M., Liu, Q., Xu, Q., Kong, X., & Lin, C. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1666884 · Cited by 6
Liu, B., Chang, H., Li, P., Chang, H., Wang, X., & He, W. (2025) · Frontiers in Physiology · doi:10.3389/fphys.2025.1729997 · Cited by 5
Cui, B., Bai, T., Wu, Q., Hu, Y., & Liu, Y. (2024) · International Journal of Implant Dentistry · doi:10.1186/s40729-024-00536-z · Cited by 5
Luo, Y., Zheng, S., Jiang, S., Yang, G., Pavel, V., Ji, H., Zhou, S., Bao, Y., Xiao, W., & Li, Y. (2024) · Osteoporosis International · doi:10.1007/s00198-024-07150-0 · Cited by 5
Qiu, D., Yan, B., Xue, H., Xu, Z., Tan, G., & Liu, Y. (2025) · Experimental Cell Research · doi:10.1016/j.yexcr.2025.114457 · Cited by 6
Weng, Z., Chen, X., Jiao, J., Fu, Z., Liu, Q., Xu, J., Zhang, H., Hou, Q., Wang, D., Li, J., et al. (2025) · Environment International · doi:10.1016/j.envint.2025.109442 · Cited by 5
Santos, R. K. F., Santos, C. B., Reis, A. R., Brandão‐Lima, P. N., de Carvalho, G. B., Martini, L. A., & Pires, L. V. (2021) · Nutrition Reviews · doi:10.1093/nutrit/nuab055 · Cited by 8
Zhu, S., Tian, A., Guo, L., Xu, H., Li, X., Wang, Z., & He, F. (2021) · Orthopaedic Surgery · doi:10.1111/os.13094 · Cited by 5
Assessment of mandibular cortical index in patients with hepatic cirrhosis: A case‐control study
Tenório, J. R., Bueno, M. V., Franco, J. B., Peres, M. P. S. D. M., Moratto, B. M. N., Munhoz, L., Arita, E. S., & Ortega, K. L. (2022) · Special Care in Dentistry · doi:10.1111/scd.12747 · Cited by 6
Impact of radiotherapy on bone health in women with rectal cancer – A prospective cohort study
Röjvall, A. S., Buchli, C., Sääf, M., Magnusson, P., Rådestad, A. F., Martling, A., & Segelman, J. (2022) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2022.06.028 · Cited by 6
Bone mass and biomarkers in young women with anorexia nervosa: a prospective 3-year follow-up study
Svedlund, A., Pettersson, C., Tubić, B., Ellegård, L., Elfvin, A., Magnusson, P., & Swolin‐Eide, D. (2022) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-022-01359-x · Cited by 7
Guo, S., Zhao, G.-Z., Chen, X., Xue, Y., Ouyang, X.-L., Liu, J.-Y., Huang, Y.-P., Liu, Y.-J., Yao, Q., Han, L.-H., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-056691 · Cited by 5
Xing, Y., Liu, J., Liu, H., & Ma, H. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s384694 · Cited by 5
Biomechanical Insights into Osteoporosis
Barkaoui, A. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.100975 · Cited by 5
Guo, H., An, Z., Wang, N., Ge, S., Cai, J. Q., Yu, S., Zhou, Y., Ying, R., Zha, K., Gu, T., et al. (2023) · Journal of Diabetes Research · doi:10.1155/2023/3872126 · Cited by 4
Kumar, S., Crumbaker, M., Harvey, C., Pathmanandavel, S., John, N., Swiha, M. M., McDonald, M. M., Clifton-Bligh, R. J., Lee, A. V., Bastick, P. A., et al. (2023) · Journal of Nuclear Medicine · doi:10.2967/jnumed.123.265759 · Cited by 5
Quan, X., Chen, H., Wang, W., Gao, Y., Zhi, X., Li, X., Yang, G., Wan, D., & An, C. (2024) · Journal of Traditional Chinese Medical Sciences · doi:10.1016/j.jtcms.2024.03.004 · Cited by 6
Singh, G., Ronald Darwin, C., Panda, K. C., Afzal, S. A., Katiyar, S., Dhakar, R. C., & Mani, S. (2024) · Journal of Biomaterials Science Polymer Edition · doi:10.1080/09205063.2024.2445376 · Cited by 7
Antiaging strategy considering physiological characteristics
Lee, H.-W., & Rhyu, H.-S. (2019) · Journal of Exercise Rehabilitation · doi:10.12965/jer.1938214.107 · Cited by 5
Jiang, X., Yan, N., Zheng, Y., Yang, J., & Zhao, Y. (2022) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-022-06014-0 · Cited by 5
Pouillès, J. M., Gosset, A., & Trémollières, F. (2021) · Gynécologie Obstétrique Fertilité & Sénologie · doi:10.1016/j.gofs.2021.03.015 · Cited by 18
Wang, K., Dang, X., Wang, Y., Yang, Q., Zhang, T., Yang, P., Yuan, L., Xu, R., Dang, Y., & Nan, Y. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1426767 · Cited by 4
Yang, Y.-J., Wang, N., Wang, X., Guo, J., Yang, B., Jia, X., & Feng, L. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202504047 · Cited by 5
Targeting ETS1 to regulate osteoporosis mediated by osteoblast paracrine dysfunction
Bai, L., Ma, C., Tang, B., Li, Q., Li, Y., Yin, W., Cai, Z., Jiang, Z., Feng, M., Cai, X., et al. (2026) · Cell Biomaterials · doi:10.1016/j.celbio.2026.100516 · Cited by 4
Clinical challenges and considerations in pharmacotherapy of osteoporosis due to menopause
Palacios, S., Rodríguez, S. P. G., Prieto, M. S., & Fasero, M. (2024) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2024.2383639 · Cited by 4
Osteoporosis and Normocalcemic Primary Hyperparathyroidism (Conservatively or Surgically Managed)
Gheorghe, A.-M., Nistor, C., Ranetti, A.-E., Ciuche, A., Ciobica, M.-L., Stanciu, M., Tănăsescu, D., Popa, F. L., & Carşote, M. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13216325 · Cited by 4
Xiang, S., Luo, Y., Liu, W., Tang, C., Zhu, T., Tian, L., Zheng, T., Long, L., Jia, M., Li, X., et al. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04009-x · Cited by 6
Chang, H., Li, Y., Wang, Z., Fang, Z., Chen, H., Xu, C., Jiao, X., & Gan, Y. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116440 · Cited by 4
Ling, R., Ai, Y., Chen, C., Zhang, J., Zou, Z., Cheng, S., Li, C., Li, X., & Wang, B. (2023) · Metabolites · doi:10.3390/metabo13030346 · Cited by 4
Yang, J., Tang, Q., Che, M., Shi, J., Yang, L., & Zeng, Y. H. (2023) · Archives of Osteoporosis · doi:10.1007/s11657-023-01345-4 · Cited by 5
Chen, L., Sun, L., Luo, B., Yu, H., Li, W., Yang, Y., & Liu, H. (2023) · BMC Psychiatry · doi:10.1186/s12888-023-05375-7 · Cited by 4
Epithelial‐like transport of mineral distinguishes bone formation from other connective tissues
Blair, H. C., Larrouture, Q. C., Tourkova, I. L., Nelson, D. J., Dobrowolski, S. F., & Schlesinger, P. H. (2023) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30494 · Cited by 4
Borgen, T. T., Lee-Ødegård, S., Eriksen, B. F., & Eriksen, E. F. (2024) · JBMR Plus · doi:10.1093/jbmrpl/ziae072 · Cited by 4
Guo, X., & Feng, H. (2024) · Gold bulletin · doi:10.1007/s13404-024-00347-5 · Cited by 4
Innovations in aggregation-induced emission materials for theranostics in the musculoskeletal system
Xu, H., Lin, S., & Hua, Y. (2024) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2024.117069 · Cited by 4
Mu, X., Zhang, H., & Zhang, J. (2025) · Orthopaedic Surgery · doi:10.1111/os.14354 · Cited by 4
Wang, L., Xu, D., Chen, M., & Huang, X. (2025) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-025-08440-2 · Cited by 4
A practical use of bone turnover markers in management of patients with skeletal fragility
Brunetti, A., Cellini, M., Vitale, V., Gentile, L. M. S., Birtolo, M. F., Vescini, F., Lania, A. G., & Mazziotti, G. (2025) · Endocrine · doi:10.1007/s12020-025-04275-y · Cited by 6
Sleep disorders and osteoporosis
Swanson, C. M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813073-5.00060-5 · Cited by 4
Zygmunt, A., Krawczyk‐Rusiecka, K., Skowrońska‐Jóźwiak, E., Wojciechowska-Durczyńska, K., Głowacka, E., Adamczewski, Z., & Lewiñski, A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10214905 · Cited by 4
Impact of Vitamin D Elements and Osteoporosis Factors in Postmenopausal Iraqi Women with T2DM
Alkabi, H., Alfatlawi, W. R., & Aldabagh, M. A. H. (2022) · Journal of Applied Sciences and Nanotechnology · doi:10.53293/jasn.2022.4483.1114 · Cited by 4
Brescia, V., Cazzolla, A. P., Fontana, A., Varraso, L., Capobianco, C., Lovero, R., Muzio, L. L., Dioguardi, M., Faienza, M. F., Crincoli, V., et al. (2023) · Applied Sciences · doi:10.3390/app131810234 · Cited by 4
Correlation study between bone metabolic markers, bone mineral density, and sarcopenia
Xie, W., He, M., Yu, D. J., Li, H., Jin, H. F., Ji, B., Yang, G., Chen, L., Rahmati, M., & Li, Y. S. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02252-8 · Cited by 4
Kong, M., Gao, C., Luan, X., Fan, C., Hao, M., Jin, C., Zhao, J., Li, H., Zhao, J., Luan, J., et al. (2024) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-024-07227-1 · Cited by 5
Tian, C., Lv, G., Li, Y., Zhao, X., Chen, M., Ye, Q., Li, Q., Zhao, J., Zhu, X., & Pan, X. (2024) · Current Stem Cell Research & Therapy · doi:10.2174/011574888x284911240131100909 · Cited by 4
Research progress of circRNA as a biomarker of osteoporosis
Du, X., Chen, Z., & Shui, W. (2024) · Frontiers in Genetics · doi:10.3389/fgene.2024.1378026 · Cited by 4
Trial Design and Statistical Considerations on the Assessment of Pharmacodynamic Similarity
Zhu, P., Hsu, C., Liao, J. J. Z., Xu, S. X., Zhang, L., & Zhou, H. (2019) · The AAPS Journal · doi:10.1208/s12248-019-0321-2 · Cited by 4
Lee, C., Wang, C., Hung, C., Huang, C., Li, C., Chen, H., Chang, Y.-L., Tseng, W.-J., Wang, T., Yang, R., et al. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.717168 · Cited by 4
Significance of Bone Turnover Marker Measurement in the Treatment of Osteoporosis
Miura, M., & Satoh, Y. (2018) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.18-00154-3 · Cited by 4
Kim, J.-W., Park, N., Kang, J., Kim, Y., Jung, H., Rim, Y. A., & Ju, J. H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22169069 · Cited by 4
Kazemi, M., Rifas‐Shiman, S. L., Yu, E. W.-Y., Wang, S., Hivert, M., Perng, W., Fitz, V. W., Shifren, J. L., Oken, E., & Chavarro, J. E. (2025) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2025.105068 · Cited by 3
Wang, H., Yu, Z., Chen, B., Xu, S., Zhou, Y., Tang, X., & Qin, Y. (2025) · Scientific Reports · doi:10.1038/s41598-025-95740-1 · Cited by 3
Xiong, K., Pan, Y., Liu, Y., Li, J., Zhan, D., Zhang, L., Li, J., & Sun, H. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.152652 · Cited by 3
Miao, T., Li, X., Zhang, W., Liu, J., Xiao, Y., & Wang, X. (2026) · Frontiers in Physiology · doi:10.3389/fphys.2025.1672997 · Cited by 3
Tuladhar, A., Carter, C. M., Vaughan, E. E., Voorbach, M. J., Kumar, P., Marinopoulos, A. E., Acharya, A., Stolarik, D. F., Sande, E., Brayman, T. G., et al. (2026) · Toxicological Sciences · doi:10.1093/toxsci/kfag026 · Cited by 3
Nasso, M. E., Bottaro, A., Fazio, M., Stagno, F., Gangemi, S., & Allegra, A. (2026) · Biomolecules · doi:10.3390/biom16050710 · Cited by 3
Мазур, І. П., & Mazur, P. V. (2023) · PAIN JOINTS SPINE · doi:10.22141/pjs.13.3.2023.384 · Cited by 3
circ_0134120: a new frontier in understanding postmenopausal osteoporosis pathogenesis
Wang, J., Zhang, H., Cao, Y., Ma, I., Liang, X., & Xiang, D. (2024) · Journal of Molecular Endocrinology · doi:10.1530/jme-23-0140 · Cited by 3
Bone Modelling and Remodelling in Cold Environment
Xue, L., Guan, Q., & Zhang, L. (2025) · Biomolecules · doi:10.3390/biom15040564 · Cited by 3
Zhao, B., Sun, X., Wang, Z., Zhi, F., & Wang, S. (2025) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-025-05897-8 · Cited by 3
Vassiliou, A. G., Jahaj, E., Mastora, Z., Karnezis, I. A., Dimopoulou, I., Orfanos, S. E., & Kotanidou, A. N. (2021) · The Journal of Critical Care Medicine · doi:10.2478/jccm-2020-0046 · Cited by 3
Effects of E2/P4 oral capsules on bone turnover in women with vasomotor symptoms
McClung, M. R., Kagan, R., Graham, S., Bernick, B., Mirkin, S., & Constantine, G. (2022) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000001915 · Cited by 3
Garnero, P., & Cremers, S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814841-9.00078-6 · Cited by 3
Vinther, C. J., Poulsen, L., Nicolaisen, P., Obling, M. L., Brix, T. H., Hermann, A. P., Hegedűs, L. D., Jørgensen, N. R., Hansen, S., & Bonnema, S. J. (2022) · Journal of Endocrinological Investigation · doi:10.1007/s40618-022-01907-2 · Cited by 3
Jia, Z., Tang, M., Zhang, X., Jiang, W., Shen, J., Zhou, N., & Hao, J. (2022) · BioMed Research International · doi:10.1155/2022/5381601 · Cited by 3
Utility of bone turnover markers in metabolic bone diseases
Aggarwal, J., Modi, M., Gupta, R. N., & Pasha, E. H. (2023) · Santosh University Journal of Health Sciences · doi:10.4103/sujhs.sujhs_38_23 · Cited by 3
Zhou, W., & Duan, T. (2023) · Open Life Sciences · doi:10.1515/biol-2022-0631 · Cited by 3
The Effects of Testosterone on Bone Turnover Markers Among Hormone-Naive Transgender Men
Chavaengkiat, S., Suwan, A., Panyakhamlerd, K., Wattanachanya, L., & Bumphenkiatikul, T. (2023) · Transgender Health · doi:10.1089/trgh.2023.0056 · Cited by 3
Giveon, S., Zacay, G., Vered, I., Foldes, A. J., & Tripto‐Shkolnik, L. (2023) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188231213639 · Cited by 3
Wang, P., Wang, X., Qian, H., Liu, J., Liu, G., Wang, R., & Liu, R. (2023) · Calcified Tissue International · doi:10.1007/s00223-023-01153-5 · Cited by 3
Zhang, P., Li, B., Chen, H., Ge, Z., Shang, Q., Liang, D., Yu, X. M., Ren, H., Jiang, X., & Cui, J. (2024) · Aging · doi:10.18632/aging.205813 · Cited by 3
Gong, C., Chen, C., Zhao, Y., Wang, Y., Li, K., Lv, X., Gao, J., Zhao, P., Fu, S., & Liu, J. (2024) · Scientific Reports · doi:10.1038/s41598-024-77620-2 · Cited by 3
Kim, S. (2025) · Maxillofacial Plastic and Reconstructive Surgery · doi:10.1186/s40902-025-00465-w · Cited by 3
Ling, M., Li, X., Xu, Y., & Fan, Y. (2021) · Archives of Osteoporosis · doi:10.1007/s11657-021-01039-9 · Cited by 3
lncRNA MEG3 Promotes PDK4/GSK-3β/β-Catenin Axis in MEFs by Targeting miR-532-5p
Yang, Y., Deng, Y., Yao, X., Luo, H., He, W.-G., Cao, X.-L., Chen, R., He, B., Jiang, H., & Wang, J. (2023) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2023/3563663 · Cited by 3
Yoshizawa, S., Shintaku, T., Ishii, H., Sakamoto, M., Musha, Y., & Ikegami, H. (2023) · Journal of Orthopaedics · doi:10.1016/j.jor.2023.07.019 · Cited by 3
Zhu, X., Weng, L.-J., Qian, X.-W., Huang, C., Yao, W., & Lu, Y. (2019) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-019-09937-w · Cited by 3
Structural and Metabolic Assessment of Bone
Narla, R. R., & Ott, S. M. (2020) · Handbook of experimental pharmacology · doi:10.1007/164_2020_376 · Cited by 4
Xu, Q., Kong, N., Zhang, Z., Cui, A., Tan, S., & Bai, N. (2022) · The American Surgeon · doi:10.1177/00031348221096574 · Cited by 2
Yang, C. H., Deng, Z., Xiang, T., Tan, J., Ling, Z., Sun, D. B., Xiao, S., Wang, X., Tang, Y., Zhang, C., et al. (2025) · Nano Today · doi:10.1016/j.nantod.2025.102671 · Cited by 2
Review of Osteoporotic Fractures: Occurrence, Prevention, and Consequences
Elias, N., Ribeiro, J. E. G., Campinho, L. A., Reis, C., Elias, L. A. M. S., & Labronici, P. J. (2025) · Revista Brasileira de Ortopedia · doi:10.1055/s-0044-1789220 · Cited by 2
Wood, A. N., & Soundy, A. (2025) · Sports · doi:10.3390/sports13120453 · Cited by 2
Zhang, Y., Huang, Y. X., Liu, X., Xiao, F., Huang, J., Wu, Y., & Yu, R. (2026) · Scientific Reports · doi:10.1038/s41598-026-35129-w · Cited by 2
Risk prediction models for postmenopausal osteoporosis: a systematic review and meta-analysis study
Li, L., Lan, X., Zeng, W., Xu, Y., & Chen, Q. (2026) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-025-09385-2 · Cited by 3
Metadata
- Authors
- Eastell, R., & Szulc, P.
- Affiliations
- University of Sheffield (GB)
- Corresponding author
- Eastell, Richard
- ORCID
- Eastell, Richard
- Venue
- The Lancet Diabetes & Endocrinology
- Publisher
- Elsevier BV
- Published
- 2017-11
- Volume
- 5
- Issue
- 11
- Pages
- 908-923
- ISSN
- 2213-8587 (ISSN-L)
- OpenAlex
- W2733907025
- Cited by
- 594
- References
- 168
- Citations by year
- 2026: 62 · 2025: 94 · 2024: 89 · 2023: 82 · 2022: 92 · 2021: 75 · 2020: 47 · 2019: 32 · 2018: 18 · 2017: 3
- FWCI
- 4.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Lancet Diabetes & Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute for Health and Care Research (NF-SI-0513-10073)
- Medical Research Council (MR/K006312/1, MR/P020941/1)
- Topics
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Oncology › Bone health and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Keywords
- bone turnover markers, postmenopausal osteoporosis, bone resorption, bone formation, P1NP, C-terminal telopeptide of type I collagen, secondary osteoporosis, fracture risk prediction
- MeSH terms
- Diphosphonates, Humans, Biomarkers, Bone Density, Osteoporosis, Postmenopausal, Bone Remodeling, Fracture Healing, Bone Density Conservation Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
